Amphora™ completed a phase III contraceptive clinical trial.

Read More


Amphora™ offers potential applications for women all over the world.

Read More


Evofem is committed
to giving women access to better healthcare options.

Read More

Empower Women logo_vChange the World

Evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. Women need access to effective products that are well suited to their lifestyle and consistent with their core values.

Latest News


Evofem, Inc. Submits New Drug Application to U.S. FDA for Amphora™ as a Contraceptive

July 6, 2015

San Diego, CA – Evofem, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of Amphora as a contraceptive vaginal gel for women.  The submission is based on the results of a large, multicenter, open-label, randomized, phase III trial that examined the…

More News